Infecting Mice with Malassezia spp. to Study the Fungus-Host Interaction
November 6th, 2019
19.1K views
This protocol outlines the establishment of a mouse model for studying Malassezia-host interactions in the skin. It describes the cultivation of Malassezia in vitro, the infection of the murine skin with Malassezia, and the subsequent analysis of the inflammation and the fungal burden in the skin tissue.
Overview
This protocol describes the establishment of a novel mouse model to study the skin fungus, Malassezia, and its interaction with mammalian skin in vivo. This model allows for the investigation of immune mechanisms against Malassezia in a tissue-specific manner, providing insights into skin disorders like atopic dermatitis.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Microbiology
Background
- Malassezia is linked to various skin disorders.
- Understanding immune responses to fungi may lead to new treatment strategies.
- This model addresses the need for studying skin commensal fungi's effects on the immune system.
- Malassezia species are classified as BSL-2 organisms in some regions.
Purpose of Study
- To develop a mouse model for studying Malassezia-host interactions.
- To analyze inflammation and fungal burden in skin tissue.
- To explore the immune response to Malassezia in the context of skin disorders.
Methods Used
- In vitro cultivation of Malassezia in mDixon medium.
- Infection of murine skin with Malassezia using an olive oil suspension.
- Measurement of ear thickness to assess inflammation.
- Quantification of fungal burden through homogenization and plating on mDixon agar.
Main Results
- Significant increase in ear thickness observed after Malassezia application.
- Fungal burden in infected skin was 100 to 1000 times above detection limits.
- Histological analysis can determine skin pathology.
- Isolation of immune cells from skin and lymph nodes to study antifungal responses.
Conclusions
- This model facilitates the study of immune responses against Malassezia.
- It provides insights into the role of Malassezia as a commensal in skin disorders.
- Further research may lead to improved treatments for chronic inflammatory skin diseases.
Frequently Asked Questions
What is Malassezia?
Malassezia is a genus of fungi associated with various skin disorders.
Why is a mouse model used?
Mouse models allow for the study of immune responses in a complex living system.
What are the safety considerations?
Malassezia species are classified as BSL-2 organisms; appropriate safety measures must be followed.
How is the fungal burden measured?
Fungal burden is quantified by homogenizing infected tissue and plating on agar.
What implications does this research have?
Understanding Malassezia-host interactions may lead to novel treatment strategies for skin disorders.
Executive Industry Relevance
This mouse model enables mechanistic de-risking of Malassezia as a therapeutic target in inflammatory skin disorders by providing a disease-relevant system to study host-fungus interactions in vivo. It supports target validation through quantitative assessment of immune responses and fungal burden, facilitating predictive confidence in preclinical programs. The model’s adaptability to genetically modified strains and compatibility with other skin disease models enhances translational continuity for biopharma R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by measuring immune responses to Malassezia in immunocompetent mice.
- Scientific Value: Supports biological de-risking through assessment of fungal burden and inflammation as functional readouts of host-pathogen crosstalk.
- Scientific Value: Clarifies mechanistic pathways by linking Malassezia exposure to measurable changes in ear thickness and immune cell recruitment.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for antifungal compound screening via standardized infection and inflammation readouts.
- Scientific Value: Provides quantitative outputs (ear thickness, CFU counts) suitable for assay standardization and dose-response analysis.
- Scientific Value: Enhances screening readiness through reproducible fungal burden quantification using mDixon agar plating.
Translational & Preclinical Research
- Scientific Value: Offers disease relevance by modeling Malassezia-driven skin inflammation in a tissue-specific context.
- Scientific Value: Enables translational biomarker alignment through histological and immune cell isolation readouts from skin and lymph nodes.
- Scientific Value: Supports risk-adjusted advancement decisions by allowing evaluation of antifungal efficacy in a physiologically relevant model.
Pipeline & Workflow Integration
The model fits within the discovery continuum from target validation through lead identification to preclinical efficacy testing, particularly for topical or systemic antifungal candidates targeting skin immune modulation.
- Discovery Biology: Facilitates hypothesis testing of Malassezia’s role in immune dysregulation via measurable inflammation and fungal load.
- Screening: Delivers assay-ready readouts including ear thickness and CFU quantification for compound evaluation.
- Analytics: Generates quantitative dependent variables (inflammation scores, fungal burden) enabling statistical comparison across treatment groups.
- Translational Research: Connects to preclinical continuity through immune cell isolation and histology, supporting biomarker-driven go/no-go decisions.
- Enterprise Reuse: Functions as a reusable platform across multiple Malassezia species and genetically modified mouse strains.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by reducing mechanistic ambiguity in Malassezia-host interactions.
- Operational Value: Ensures reproducibility through standardized inoculation, infection, and quantification procedures.
- Strategic Value: Improves go/no-go decisions by providing objective inflammation and burden metrics prior to lead optimization.
- Portfolio Impact: Enables risk-adjusted prioritization of antifungal candidates based on in vivo skin model performance.
Implementation Considerations
- Requires expertise in murine handling, fungal BSL-2 protocols, and skin immune assays.
- Necessitates incubators with shaking capability, centrifuges, spectrometers for OD600, and homogenization equipment.
- Demands cross-team standardization of ear thickness measurement and fungal burden quantification techniques.
- Requires adaptation considerations when extending to other Malassezia species or alternative skin challenge models.
- Practical limitations include fungal aggregation in oil suspensions, necessitating extensive vortexing for consistent dosing.
Biopharma FAQs
Why does ear thickness measurement matter for target validation?
Ear thickness quantification provides a direct, in vivo readout of inflammation, enabling assessment of Malassezia-induced immune activation as a functional biomarker for target engagement in skin disorder models.
How does fungal burden quantification support assay development?
Fungal burden measured via homogenization and plating on mDixon agar yields quantitative CFU data, establishing a standardized assay for evaluating antifungal efficacy and colonization levels in infected tissue.
What immune cell isolation enables mechanistic de-risking?
Isolation of immune cells from skin and draining lymph nodes allows investigation of antifungal responses, helping de-risk targets by linking Malassezia exposure to specific immune modulation relevant to inflammatory skin diseases.
Why are replication requirements important for cross-functional collaboration?
Replication across experiments ensures consistent inflammation and burden readouts, enabling reliable data sharing between discovery, toxicology, and clinical teams for aligned go/no-go decisions.
What statistical analysis is required before implementing this model in screening?
Statistical analysis of ear thickness and fungal burden data is required to establish significance thresholds and variability metrics, ensuring the model’s robustness for hit-to-lead progression in antifungal programs.
